Prosecution Insights
Last updated: April 19, 2026

Stoke Therapeutics, Inc.

4 pending office actions

Portfolio Summary

4
Total Pending OAs
3
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18483333 OPA1 ANTISENSE OLIGOMERS FOR TREATMENT OF CONDITIONS AND DISEASES WHITEMAN, BRIAN A 1636 Final Rejection Oct 09, 2023
17832182 ANTISENSE OLIGOMERS FOR TREATMENT OF CONDITIONS AND DISEASES POLIAKOVA-GEORGAN, EKATERINA 1637 Final Rejection Jun 03, 2022
17673226 COMPOSITIONS AND METHODS FOR MODULATING SPLICING AND PROTEIN EXPRESSION MCLEOD, AFRICA MHAIRIE 1635 Final Rejection Feb 16, 2022
17518209 METHODS AND COMPOSITIONS FOR MODULATING SPLICING AND TRANSLATION REGA, KYLE THOMAS 1636 Non-Final OA Nov 03, 2021

Managing Stoke Therapeutics, Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month